Abstract:Macrocyclic peptides are predominantly peptide structures bearing one or more rings and spanning multiple amino acid residues. Macrocyclization has become a common approach for improving the pharmacological properties and bioactivity of peptides. A variety of ribosomal-derived and non-ribosomal synthesized cyclization approaches have been established. The biosynthesis of backbone macrocyclic peptides using seven new emerging methodologies will be discussed with regard to the features and strengths of each platform rather than medicinal chemistry tools. The mRNA display variant, known as the random nonstandard peptide integrated discovery (RaPID) platform, utilizes flexible in vitro translation (FIT) to access macrocyclic peptides containing nonproteinogenic amino acids (NAAs). As a new discovery approach, the ribosomally synthesized and post-translationally modified peptides (RiPPs) method involves the combination of ribosomal synthesis and the phage screening platform together with macrocyclization chemistries to generate libraries of macrocyclic peptides. Meanwhile, the split-intein circular ligation of peptides and proteins (SICLOPPS) approach relies on the in vivo production of macrocyclic peptides. In vitro and in vivo peptide library screening is discussed as an advanced strategy for cyclic peptide selection. Specifically, biosynthetic bicyclic peptides are highlighted as versatile and attractive modalities. Bicyclic peptides represent another type of promising therapeutics that allow for building blocks with a heterotrimeric conjugate to address intractable challenges and enable multimer complexes via linkers. Additionally, we discuss the cell-free chemoenzymatic synthesis of macrocyclic peptides with a non-ribosomal catalase known as the non-ribosomal synthetase (NRPS) and chemo-enzymatic approach, with recombinant thioesterase (TE) domains. Novel insights into the use of peptide library tools, activity-based two-hybrid screening, structure diversification, inclusion of NAAs, combinatorial libraries, expanding the toolbox for macrocyclic peptides, bicyclic peptides, chemoenzymatic strategies, and future perspectives are presented. This review highlights the broad spectrum of strategy classes, novel platforms, structure diversity, chemical space, and functionalities of macrocyclic peptides enabled by emerging biosynthetic platforms to achieve bioactivity and for therapeutic purposes.

Cyclic Peptides from Graspetide Biosynthesis and Native Chemical Ligation

Characterization of a Dual Function Peptide Cyclase in Graspetide Biosynthesis

P450‐Modified Multicyclic Cyclophane‐Containing Ribosomally Synthesized and Post‐Translationally Modified Peptides

Phylogenomic analysis of the diversity of graspetides and proteins involved in their biosynthesis

P450-Modified Ribosomally Synthesized Peptides with Aromatic Cross-Links.

P450-Catalyzed Biaryl Macrocyclization of Leaderless Ribosomal Peptides

Biosynthesis of macrocyclic peptides with C-terminal β-amino-α-keto acid groups by three different metalloenzymes

Rapid Peptide Cyclization Inspired by the Modular Logic of Nonribosomal Peptide Synthetases

Current Synthetic Approaches to Peptide and Peptidomimetic Cyclization

Biosynthetic Strategies for Macrocyclic Peptides

Daropeptide natural products

Cyclotides, a Novel Ultrastable Polypeptide Scaffold for Drug Discovery

Efficient Enzymatic Cyclization of Disulfide-Rich Peptides by Using Peptide Ligases

Expanding the chemical space of synthetic cyclic peptides using a promiscuous macrocyclase from prenylagaramide biosynthesis

Chemical Synthesis of a Cyclotide Via Intramolecular Cyclization of Peptide O-esters

Peptide Macrocyclization Through Palladium-Catalyzed Late-Stage C-H Activation.

An intramolecular macrocyclase in plant ribosomal peptide biosynthesis

Peptide/protein-based Macrocycles: from Biological Synthesis to Biomedical Applications

Structural Basis of Nonribosomal Peptide Macrocyclization in Fungi

Structural Investigation Of Ribosomally Synthesized Natural Products By Hypothetical Structure Enumeration And Evaluation Using Tandem Ms

Histidine-bridged cyclic peptide natural products: isolation, biosynthesis and synthetic studies